{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:03:24Z","timestamp":1761894204270},"reference-count":47,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T00:00:00Z","timestamp":1133222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2006,1]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p><jats:bold>Objectives.\u2002<\/jats:bold> Familial combined hyperlipidaemia (FCH) is associated with insulin resistance. We hypothesized that pioglitazone treatment of FCH patients might increase insulin sensitivity, but may also improve serum lipid levels, body fat distribution, intramyocellular lipids (IMCL) and endothelial function.<\/jats:p><jats:p><jats:bold>Design.\u2002<\/jats:bold> Double blind, randomized, cross\u2010over study.<\/jats:p><jats:p><jats:bold>Subjects.\u2002<\/jats:bold> Seventeen FCH patients.<\/jats:p><jats:p><jats:bold>Interventions.\u2002<\/jats:bold> Sixteen weeks of pioglitazone treatment (30\u2003mg) compared with 16\u2003weeks of placebo.<\/jats:p><jats:p><jats:bold>Main outcome measurements.\u2002<\/jats:bold> Insulin sensitivity was measured using the hyperinsulinaemic euglycaemic clamp procedure, body fat distribution and IMCL using magnetic resonance techniques and endothelial function using flow\u2010mediated vasodilatation.<\/jats:p><jats:p><jats:bold>Results.\u2002<\/jats:bold> Pioglitazone improved insulin sensitivity (<jats:italic>M<\/jats:italic> value 37.7\u2003\u00b1\u20033.6\u2003<jats:italic>\u03bc<\/jats:italic>mol\u2003min<jats:sup>\u22121<\/jats:sup>\u2003kg<jats:sup>\u22121<\/jats:sup> vs. 33.0\u2003\u00b1 3.3\u2003<jats:italic>\u03bc<\/jats:italic>mol\u2003min<jats:sup>\u22121<\/jats:sup>\u2003kg<jats:sup>\u22121<\/jats:sup> during placebo, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05) and LDL composition by increasing the <jats:italic>K<\/jats:italic> value (\u22120.11\u2003\u00b1\u20030.06 vs. \u22120.20\u2003\u00b1\u20030.06 during placebo, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). However, pioglitazone did not affect other serum lipid levels. Endothelial function, body fat distribution and IMCL were also not affected. In addition, pioglitazone was associated with a decrease in liver enzymes (alkaline phosphatase).<\/jats:p><jats:p><jats:bold>Conclusion.\u2002<\/jats:bold> Pioglitazone treatment of FCH patients without type 2 diabetes mellitus increases insulin sensitivity, decreases liver enzymes and improves LDL composition but has a neutral effect on total serum lipid levels. The change in insulin sensitivity might be too small to induce changes in endothelial function, body fat distribution and IMCL.<\/jats:p>","DOI":"10.1111\/j.1365-2796.2005.01579.x","type":"journal-article","created":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T16:34:52Z","timestamp":1133282092000},"page":"107-116","source":"Crossref","is-referenced-by-count":7,"title":["Effects of pioglitazone in familial combined hyperlipidaemia"],"prefix":"10.1111","volume":"259","author":[{"given":"E. J.","family":"ABBINK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"DE GRAAF","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H.","family":"DE HAAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"HEERSCHAP","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. F.","family":"STALENHOEF","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. J.","family":"TACK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,11,29]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1997.1850734.x"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041433-199806000-00002"},{"issue":"42","key":"e_1_2_10_4_2","first-page":"46","article-title":"Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids","volume":"95","author":"De Graaf J","year":"2002","journal-title":"J R Soc Med"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1320"},{"key":"e_1_2_10_6_2","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/ATVB.17v07.1465","article-title":"Nonobese patients with familial combined hyperlipidemia are insulin resistant compared with their nonaffected relatives","volume":"17","author":"Bredie SJ","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80191-0"},{"key":"e_1_2_10_8_2","first-page":"177","article-title":"Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes","volume":"5","author":"DeFronzo RA","year":"1997","journal-title":"Diabetes Rev"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.1999.00023.x"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041001"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.6.908"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030723"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020963"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-1-200101020-00014"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000090521.25968.4D"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.4.708"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90074-4"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.19.2097"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.1.41"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.9.2588"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000016049.86468.23"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(97)00164-7"},{"key":"e_1_2_10_23_2","first-page":"R660","article-title":"Effect of pioglitazone on vascular reactivity in vivo and in vitro","volume":"270","author":"Kotchen TA","year":"1996","journal-title":"Am J Physiol"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2.484"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.5.933"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06417.x"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000130646.93255.86"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(81)90074-3"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.5.749"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.7.8638"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.1910090110"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.2002.282.1.E95"},{"key":"e_1_2_10_33_2","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/clinchem\/26.13.1775","article-title":"A study of the use of polyethylene glycol in estimating cholesterol in high\u2010density lipoprotein","volume":"26","author":"Demacker PN","year":"1980","journal-title":"Clin Chem"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"e_1_2_10_35_2","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0022-2275(20)38613-2","article-title":"Single spin density gradient ultracentrifugation method for the detection and isolation of light and heavy low density lipoprotein subfractions","volume":"28","author":"Swinkels DW","year":"1987","journal-title":"J Lipid Res"},{"key":"e_1_2_10_36_2","first-page":"1295","article-title":"Both inherited susceptibility and environmental exposure determine the low\u2010density lipoprotein\u2010subfraction pattern distribution in healthy Dutch families","volume":"51","author":"Graaf J","year":"1992","journal-title":"Am J Hum Genet"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00381-6"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00432-9"},{"key":"e_1_2_10_39_2","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/clinchem\/26.8.1205","article-title":"Immunonephelometric assay of human apolipoprotein AI","volume":"26","author":"Lopes\u2010Virella MF","year":"1980","journal-title":"Clin Chem"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.269"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1979.237.3.E214"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00713-6"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.6.8567"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.3.797"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031315"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.3.603"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(03)00296-X"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2005.01579.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.2005.01579.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T20:37:06Z","timestamp":1697143026000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2005.01579.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,29]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.1111\/j.1365-2796.2005.01579.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2005.01579.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,29]]}}}